MarketPeel
Insider Trading Intelligence
NK

Nadav Kidron

ORMP
PRESIDENT AND CEO · ORAMED PHARMACEUTICALS INC. · CIK 0001351779
FILING MIX · LIFETIME70%/30%
BUYS
28
SELLS
12
TOTAL VALUE
$11.12M
COMPANIES
2
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
3,429,900
AVG SELL PX
$17.34
TRADE KIND
SHOWING 40 / 40
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Nadav Kidron, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+66.67%-7.82%+0.98%-8.81%-1.45%
14d3+66.67%-7.76%+1.61%-9.37%-4.57%
30d3+100.00%+0.39%+4.15%-3.77%-3.17%
60d3+66.67%+28.11%+3.16%+24.95%+29.94%
90d3+66.67%+67.92%+9.45%+58.47%+63.87%
180d3+100.00%+12.53%+10.32%+2.21%+25.02%
1y3+100.00%+1.75%+19.72%-17.97%-1.18%
2y3+100.00%-20.82%+31.59%-52.41%-37.95%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORMP · 3,422,243 shares · as of Mar 30, 2026
0855,5611,711,1222,566,6823,422,243202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 28 buys / 12 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
44,818$3.31$148.3K3,422,243Mar 30, 2026Mar 31, 2026View →
LFWD
LIFEWARD LTD.
PURCHASEGRANT
Stock grant
7,6577,657Mar 25, 2026Mar 27, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
167,0053,422,243Mar 17, 2026Mar 18, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALEGRANT
Gift
100,0003,255,238Mar 12, 2026Mar 16, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
109,0000Jan 22, 2026Jan 29, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
President and CEO
109,0003,355,238Jan 22, 2026Jan 29, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
327,0003,246,238Dec 31, 2025Jan 5, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
232,6402,919,238Dec 31, 2025Jan 5, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
109,000109,000Dec 31, 2025Jan 5, 2026View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
100,0002,686,598Feb 11, 2025Feb 11, 2025View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
141,0002,400,598Feb 11, 2025Feb 11, 2025View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
186,0002,586,598Feb 11, 2025Feb 11, 2025View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
433,5002,259,598Jan 2, 2025Jan 6, 2025View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
45,0001,826,098Nov 7, 2024Nov 8, 2024View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
329,0001,781,098Jan 4, 2024Jan 8, 2024View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
120,0001,452,098May 26, 2023May 31, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
279,0001,332,098Apr 17, 2023Apr 20, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
President and CEO
26,000$2.04$53.0K126,000Mar 16, 2023Mar 16, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASE
President and CEO
100,000$2.01$201.0K100,000Mar 14, 2023Mar 15, 2023View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALEGRANT
Gift
25,0001,053,098Oct 27, 2022Oct 28, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
12,631$8.36$105.6K1,078,098Aug 1, 2022Aug 1, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
126,0001,090,729Jul 28, 2022Aug 1, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
34,000964,729Jul 28, 2022Aug 1, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
107,000107,000Jan 3, 2022Jan 11, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
150,000916,481Jan 3, 2022Jan 11, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
63,000930,729Jan 3, 2022Jan 11, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
48,752$13.89$677.2K867,729Jan 3, 2022Jan 11, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
63,000950,729Jan 3, 2022Jan 5, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
150,000936,481Jan 3, 2022Jan 5, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
48,752$13.89$677.2K887,729Jan 3, 2022Jan 5, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
107,000107,000Jan 3, 2022Jan 5, 2022View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALEGRANT
Gift
20,000766,481Dec 30, 2021Dec 30, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
31,728$12.98$411.8K786,481Dec 28, 2021Dec 30, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALEGRANT
Gift
20,000818,209Dec 3, 2021Dec 7, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
100,000838,209Aug 31, 2021Dec 7, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
100,000748,573Aug 31, 2021Sep 2, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
220,000$20.11$4.42M738,209Aug 9, 2021Dec 7, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
SALE
President and CEO
220,000$20.11$4.42M648,573Aug 9, 2021Aug 11, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
150,000150,000Feb 3, 2021Feb 8, 2021View →
ORMP
ORAMED PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
190,000190,000Jan 8, 2020Jan 14, 2020View →
Other insiders · ORMP
Loading peer insiders…
About this filer
CIK 0001351779
ROLE
President and CEO
PRIMARY
ORMP
COMPANIES
2
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001351779DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback